Navigation Links
Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
Date:11/10/2009

) (3,512,716) (1) (4,060,906) (1) ---------- ---------- ---------- ---------- Loss from operations (7,086,173) (13,596,752) (6,591,423) (5) (11,979,119) ---------- ----------- ---------- ----------- Interest income (expense), net (5,878,853) 95,664 (1,664,225) 95,664 Change in fair value of derivative liabilities (12,509,518) - - (2) - ----------- --- --- --- Loss from continuing operations (25,474,544) (13,501,088) (8,255,648) (11,883,455) Loss from discontinued operations (1,930,636) (6,019,017) (1,930,636) (6,019,017) Gain on sale of business unit 6,408,603 - 6,408,603 - ========= === ========= === Net loss $(20,996,577) $(19,520,105) $(3,777,681) $(17,902,472) ============ ============ =========== ============ Net loss per common share - basic and diluted $(0.44) $(0.44) $(0.08) $(0.40) ====== ====== ====== ====== Weighted average common shares outstanding - basic and diluted 47,214,142 44,322,663 47,214,142 44,322,663
                Selected Condensed Consolidated Balance Sheet Data

                             GAAP Financials         Non-GAAP Proforma

                                                   Pro forma     Pro Forma
                    September 30,  December 31,     Results       Results
                        2009          2008        September 30,  December 31,
                     (Unaudited)    (Audited)        2009*          2008*
                     ----------     ----------    --------
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Cardium Completes $5.3 Million Registered Direct Offering
3. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
4. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
5. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
10. Cardium Launches New AWARE Clinical Study Website
11. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... SoundConnect , an award winning unified communications ... Darren Suders has joined the team as Director of ... partner program through innovative offerings, consistent partner ... brings more than 10-years of channel telecommunication experience to ... from policy development, to partner education and to expansion. ...
(Date:11/26/2014)... , Nov. 25, 2014 Bio-Techne Corporation ... has appointed Robert Gavin to serve in ... the Protein Platforms Division.  Mr. Gavin will be responsible ... segment, which includes the ProteinSimple business acquired in July ... San Jose, California -based ProteinSimple develops ...
(Date:11/24/2014)... -- Five American winners will receive the ... for Medical Sciences", in its 8 th term; ... , on 15 December 2014.      (Photo: ... Center which won the Hamdan Award for Volunteers in ... that aim to improve health and promote peace and ...
(Date:11/24/2014)... Nov. 24, 2014   Veracyte, Inc. (Nasdaq: ... , president and chief executive officer, will present in a ... Annual Healthcare Conference on Tuesday, December 2, 2014 at 12:30 ... The live audio webcast and subsequent replay may be ... connect to the website at least 15 minutes prior to ...
Breaking Biology Technology:SoundConnect Appoints Director of Channel Development & Sales 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3Five US Winners Among Recipients of Hamdan Medical Awards 2Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2
... 13, 2011 Tengion, Inc. (NASDAQ: TNGN ... new data from the Company,s Neo-Urinary Conduit™ (NUC) and ... at the TERMIS North America Annual Conference being held ... NUC program is further supported by various cellular and ...
... Dec. 13, 2011  Astellas Pharma Inc. (Tokyo: 4503, Astellas) ... from an interim analysis of a Phase 2 study ... were presented at the 53rd Annual Meeting of the ... Data were also presented from two additional posters: one ...
... PHILADELPHIA, Dec. 13, 2011 Tarsa Therapeutics today confirmed ... Application (NDA) to the Food and Drug Administration (FDA) ... company,s oral recombinant salmon calcitonin tablet for the treatment ... the FDA that verified the results from Tarsa,s Phase ...
Cached Biology Technology:Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 2Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 3Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 4Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 2Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 3Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 4Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 5Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 6Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 7Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 8Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin 2Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin 3
(Date:11/4/2014)... only marketing directed at children on the interior ... that the majority of black, middle-income and rural ... , Authored by Arizona State University researcher Punam ... first to examine the use of child-directed marketing ... restaurants and its relationship to demographics. It adds ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and Markets ... "Cell Therapy - Technologies, Markets and Companies" to their ... therapy technologies and methods, which have already started to play ... cell transplantation is replacing the old fashioned bone marrow transplants. ... therapy is bound to become a part of medical practice. ...
(Date:11/2/2014)... of Physics World , James Dacey explores the ... death" to take their innovations from the lab into ... challenge facing all start-up companies as they move from ... of two main factors: physics-based inventions are usually far ... out to be a lot more complicated than had ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3The 'valley of death' facing physics start-ups 2
... human survival and food security, especially as population density ... social insects to cultivate crops, have harvested plant material ... years. New results from the Smithsonian show that both ... coming into the nest inside leaves, thus ensuring the ...
... year, hundreds of thousands of people suffer medical complications ... skin. A new device developed by MIT engineers and ... needles on target. The device, which is purely ... industry. It involves a hollow S-shaped needle containing a ...
... has joined with a team of colleagues to propose ... research field that investigates heritable alterations in gene expression ... Dr. Shilatifard,s publication appeared today in ... meeting on December 7-10, 2008 that he co-organized at ...
Cached Biology News:Food security for leaf-cutting ants: Workers and their fungus garden reject endophyte invaders 2MIT: Novel needle could cut medical complications 2Ali Shilatifard and colleagues aim to clarify the definition of 'epigenetics' 2
... Kit, 500 reactions. Prepare circular DNA ... h.Generate microgram quantities of template DNA ... amplified DNA directly for cycle sequencing ... M13 liquid cultures, colonies, plaques, or ...
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
Mixing speed from 750-3200RPM, small vortexing orbit of1.0mm...
This Universal 24" X 18" (61 X 45.7cm.) shaker platforms will accept any Thermo Forma shaker flask clip....
Biology Products: